Videos / Enteric coated risedronate 35mg for the treatment of osteoporosis
In this Product Explainer, Endocrinologist Prof Ego Seeman explains the role of enteric coated risedronate 35mg for the treatment of osteoporosis (5 mins).

Weight Management in Women of Reproductive Age

New Spirometry Standards: Key Changes for Clinical Practice

Food Allergy Prevention

Protecting Young Lungs – Paediatric Insights into RSV

expert
Endocrinologist; Dept of Medicine and Endocrinology, Austin Health, University of Melbourne; Editor, Progress in Osteoporosis